Burden of Influenza at Emergency Department (ED) Level in European Countries

NCT04244500 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2020-01-28

No results posted yet for this study

Summary

This study plans to conduct enhanced influenza surveillance at a hospital emergency department level independent of underlying influenza-like symptoms.

Conditions

  • Influenza, Human

Interventions

PROCEDURE

swab sampling

Multiplex polymerase chain reaction assay for organisms of upper respiratory tract infections

Sponsors & Collaborators

  • Klinikum Ernst von Bergmann Potsdam

    collaborator UNKNOWN
  • Klinikum Suedstadt, Rostock

    collaborator UNKNOWN
  • Sanofi Pasteur, a Sanofi Company

    collaborator INDUSTRY
  • University of Rostock

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-27
Primary Completion
2020-04-30
Completion
2020-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04244500 on ClinicalTrials.gov